NewsRoom Articles - Page 31 of 154 - PsychedelicNewsWire (PNW)

TuesdayMay 23, 2023 3:52 pm

OSU Awarded License to Grow Psilocybin Mushrooms for DEA Research

Research into psychedelics has increased significantly in the recent years, as we learn more about their beneficial properties. Before the psychedelic renaissance, trials on the effectiveness of psilocybin were conducted in the 1960s. However, research grinded to a halt following the classification of the drug as a Schedule I substance. The DEA recently awarded the Ohio State University a license to cultivate hallucinogenic mushrooms for research purposes. This license was awarded to OSU together with a mental health and wellness research and development company focused on psychedelics, Inner State Inc. This makes Ohio State the first university in the country…

MondayMay 22, 2023 12:06 pm

More Firms Enter Psychedelic Field to Develop Mental Health Treatments

Psychedelic reform is gaining traction in the United States as more states introduce measures to decriminalize and legalize the use of these substances. This is primarily due to a significant increase of interest in these drugs in the recent years as more studies uncover the therapeutic benefits that psychedelics possess. Thus far, numerous studies have found that psychedelics such as MDMA, psilocybin and ketamine may help manage symptoms of anxiety and depression, reduce OCD symptoms, improve mood and improve symptoms of post-traumatic stress disorder. In 2017, the FDA even granted breakthrough therapy designations to psychedelic therapies using psilocybin to treat…

FridayMay 19, 2023 11:24 am

Colorado NGO Behind CBD for Pediatric Epilepsy Shifts Attention to Psychedelics Via Sister Organization

Last year, the Stanley Brothers signed a partnership between a professional sports league and a hemp/marijuana brand, becoming the first to do so. Prior to this, the company’s CBD products, including Charlotte’s Web, had been gaining popularity in Colorado, especially after a surge in their use by children with epileptic seizures. Paige Figi, mother to the late Charlotte, who experienced seizures on a daily basis, was the first to discover this benefit. Together with Heather Jackson, whose son also used Charlotte’s Web, Figi founded Realm of Caring to conduct more studies into CBD in 2013. Many years later, medical cannabis…

ThursdayMay 18, 2023 3:19 pm

Five Scientific Discoveries about Psychedelic Substances, Their Effects

Interest in psychedelics has increased significantly in recent years, with numerous studies being conducted on DMT, MDMA, LSD and psilocybin mushrooms. These substances are known to alter cognition, perception and mood when consumed, with researchers finding that they also possess therapeutic benefits that may be useful in the treatment of mental health conditions such as anxiety, depression, addiction and PTSD. Today, we look at some of the discoveries related to psychedelic drugs and their therapeutic potential. Psychedelics may help manage alcohol abuse. One study has determined that a combination of 5-MeO-DMT and ibogaine treatments may help reduce symptoms of PTSD…

WednesdayMay 17, 2023 3:07 pm

Study Identifies Where Psychedelics Users Find Reliable Information

Interest in psychedelics has increased greatly in the last decade or so, as new studies into the treatment of various mental health conditions using these drugs are conducted. As more positive benefits are discovered, we have seen changes to laws that previously prohibited access to the use of psychedelics as well as the emergence of psychedelic NGOs and psychedelic startups. In an effort to inform harm reduction and education programs that address illicit and legal use of psychedelics, researchers looked into information-seeking behaviors of individuals who used psychedelics. The study was led by Dr. Daniel Kruger, a researcher at the…

TuesdayMay 16, 2023 3:48 pm

Beckley Psytech Commences Phase 2a Trial for Treatment-Resistant Depression

Beckley Psytech is a clinical-stage biotechnology company focused on improving the lives of individuals living with neuropsychiatric disorders through the development of psychedelic drugs. In its latest press release, the company revealed that it has administered a new intranasal psychedelic using an FDA-approved delivery device to a patient with treatment-resistant depression during a phase 2a trial. The objective of the phase 2 trial is to assess the effectiveness, safety and pharmacokinetics of the company’s BPL-003 formulation when administered together with psychological support, to patients experiencing moderate to severe symptoms of treatment-resistant depression. BPL-003 is a synthetic formulation of the 5-MeO-DMT…

MondayMay 15, 2023 3:54 pm

Vermont Legislators Discuss Plans to Approve Legalization of Psilocybin

Legislators in Vermont recently discussed a bill to legalize psilocybin and begin offering regulated access to the drug. The state of Vermont is one of many states where legislators have shown interest in advancing psychedelic reform. The bill in question, H. 371, was sponsored by Representatives Chip Troiano and Brian Cina. While the members of the House Judiciary Committee did seem to agree to the bill’s overall merits, the chair noted that there wasn’t enough floor time left before legislators adjourned. This means that the legislation will be advanced at the start of next year. Cina stated that he had,…

FridayMay 12, 2023 3:03 pm

Dietary Tips to Consider Before, During, After a Psychedelic Trip

Interest in psychedelics has increased greatly in the recent years, with numerous studies finding that these substances hold the therapeutic potential to treat a range of mental health conditions. Some are also turning to the drugs to help explore their consciousness and improve their creativity. However, like any other recreational substance, the trip may not always be good. Psychedelics such as LSD, psilocybin, MDMA and peyote can deplete the body’s nutrient stores. If an individual is running low on crucial vitamins and minerals, one may feel ill during or after their psychedelic trip. To help prepare for a psychedelic trip,…

ThursdayMay 11, 2023 3:46 pm

Case Study Highlights Potential of Psilocybin to Improve Color Blindness

Studies have, in the past, associated the dilation of pupils, unexpected saccades and trippy details with the consumption of drugs such as DMT, psilocybin mushrooms and LSD. Now, a new case study has established a link between human vision and psychedelic substances. This may be the first study to offer comprehensive proof of a psychedelic drug reversing a color blindness diagnosis, albeit temporarily. Color blindness is a condition that causes individuals to see colors differently than most people. This congenital condition is brought on by gene mutations that change cones, which are structures in the eye that detect and covert…

WednesdayMay 10, 2023 3:36 pm

Oregon Licenses First Psilocybin Service Facility to Administer Psychedelic Therapies

Regulators in Oregon have awarded a license for the first psilocybin service center in the nation to EPIC Healing Eugene. The facility will allow individuals in need to receive the psychedelic in a facilitated and supervised environment. With this move, the state has now officially approved a license for each of the four business categories established by the psilocybin law. In a press release, Oregon Psilocybin Services Section Manager Angie Allbee stated that this was a historic moment with psilocybin services becoming more available in the state. The Oregon Health Authority has, in the last few weeks, approved various permits…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000